These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 12665398

  • 1. Clozapine: in prevention of suicide in patients with schizophrenia or schizoaffective disorder.
    Wagstaff A, Perry C.
    CNS Drugs; 2003; 17(4):273-80; discussion 281-3. PubMed ID: 12665398
    [Abstract] [Full Text] [Related]

  • 2. The international suicide prevention trial (interSePT): rationale and design of a trial comparing the relative ability of clozapine and olanzapine to reduce suicidal behavior in schizophrenia and schizoaffective patients.
    Alphs L, Anand R, Islam MZ, Meltzer HY, Kane JM, Krishnan R, Green AI, Potkin S, Chouinard G, Lindenmayer JP, Kerwin R.
    Schizophr Bull; 2004; 30(3):577-86. PubMed ID: 15631247
    [Abstract] [Full Text] [Related]

  • 3. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).
    Meltzer HY, Alphs L, Green AI, Altamura AC, Anand R, Bertoldi A, Bourgeois M, Chouinard G, Islam MZ, Kane J, Krishnan R, Lindenmayer JP, Potkin S, International Suicide Prevention Trial Study Group.
    Arch Gen Psychiatry; 2003 Jan; 60(1):82-91. PubMed ID: 12511175
    [Abstract] [Full Text] [Related]

  • 4. [Psychoses, mood, suicidal tendencies and clozapine].
    Llorca PM, Lançon C, Reine G.
    Encephale; 1997 Jan; 23(6):431-6. PubMed ID: 9488925
    [Abstract] [Full Text] [Related]

  • 5. Suicide prevention effects associated with clozapine therapy in schizophrenia and schizoaffective disorder.
    Reid WH, Mason M, Hogan T.
    Psychiatr Serv; 1998 Aug; 49(8):1029-33. PubMed ID: 9712207
    [Abstract] [Full Text] [Related]

  • 6. A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia.
    Meltzer HY, Bobo WV, Roy A, Jayathilake K, Chen Y, Ertugrul A, Anil Yağcioğlu AE, Small JG.
    J Clin Psychiatry; 2008 Feb; 69(2):274-85. PubMed ID: 18232726
    [Abstract] [Full Text] [Related]

  • 7. Clozapine for treatment-refractory schizophrenia, schizoaffective disorder, and psychotic bipolar disorder: a 24-month naturalistic study.
    Ciapparelli A, Dell'Osso L, Pini S, Chiavacci MC, Fenzi M, Cassano GB.
    J Clin Psychiatry; 2000 May; 61(5):329-34. PubMed ID: 10847306
    [Abstract] [Full Text] [Related]

  • 8. Risperidone augmentation of clozapine: a critical review.
    Kontaxakis VP, Ferentinos PP, Havaki-Kontaxaki BJ, Paplos KG, Pappa DA, Christodoulou GN.
    Eur Arch Psychiatry Clin Neurosci; 2006 Sep; 256(6):350-5. PubMed ID: 16900439
    [Abstract] [Full Text] [Related]

  • 9. Patterns of concomitant psychotropic medication use during a 2-year study comparing clozapine and olanzapine for the prevention of suicidal behavior.
    Glick ID, Zaninelli R, Hsu C, Young FK, Weiss L, Gunay I, Kumar V.
    J Clin Psychiatry; 2004 May; 65(5):679-85. PubMed ID: 15163255
    [Abstract] [Full Text] [Related]

  • 10. Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis.
    Henderson DC, Cagliero E, Copeland PM, Borba CP, Evins AE, Hayden D, Weber MT, Anderson EJ, Allison DB, Daley TB, Schoenfeld D, Goff DC.
    Arch Gen Psychiatry; 2005 Jan; 62(1):19-28. PubMed ID: 15630069
    [Abstract] [Full Text] [Related]

  • 11. Predicting suicidal risk in schizophrenic and schizoaffective patients in a prospective two-year trial.
    Potkin SG, Alphs L, Hsu C, Krishnan KR, Anand R, Young FK, Meltzer H, Green A, InterSePT Study Group.
    Biol Psychiatry; 2003 Aug 15; 54(4):444-52. PubMed ID: 12915289
    [Abstract] [Full Text] [Related]

  • 12. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
    Swainston Harrison T, Perry CM.
    Drugs; 2004 Aug 15; 64(15):1715-36. PubMed ID: 15257633
    [Abstract] [Full Text] [Related]

  • 13. Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment.
    Meltzer HY, Okayli G.
    Am J Psychiatry; 1995 Feb 15; 152(2):183-90. PubMed ID: 7840350
    [Abstract] [Full Text] [Related]

  • 14. Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.
    Citrome L, Volavka J, Czobor P, Sheitman B, Lindenmayer JP, McEvoy J, Cooper TB, Chakos M, Lieberman JA.
    Psychiatr Serv; 2001 Nov 15; 52(11):1510-4. PubMed ID: 11684748
    [Abstract] [Full Text] [Related]

  • 15. Prevention of suicide by clozapine in mental disorders: systematic review.
    Masdrakis VG, Baldwin DS.
    Eur Neuropsychopharmacol; 2023 Apr 15; 69():4-23. PubMed ID: 36640481
    [Abstract] [Full Text] [Related]

  • 16. Switching clozapine responders to olanzapine.
    Littrell KH, Johnson CG, Hilligoss NM, Peabody CD, Littrell SH.
    J Clin Psychiatry; 2000 Dec 15; 61(12):912-5. PubMed ID: 11206595
    [Abstract] [Full Text] [Related]

  • 17. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
    Tauscher J, Hussain T, Agid O, Verhoeff NP, Wilson AA, Houle S, Remington G, Zipursky RB, Kapur S.
    Am J Psychiatry; 2004 Sep 15; 161(9):1620-5. PubMed ID: 15337652
    [Abstract] [Full Text] [Related]

  • 18. Concentrations in plasma clozapine levels in schizophrenic and schizoaffective patients.
    Iglesias García C, Iglesias Alonso A, Bobes J.
    Rev Psiquiatr Salud Ment; 2017 Sep 15; 10(4):192-196. PubMed ID: 28844295
    [Abstract] [Full Text] [Related]

  • 19. IBZM SPECT imaging of striatal dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidol.
    Küfferle B, Tauscher J, Asenbaum S, Vesely C, Podreka I, Brücke T, Kasper S.
    Psychopharmacology (Berl); 1997 Oct 15; 133(4):323-8. PubMed ID: 9372530
    [Abstract] [Full Text] [Related]

  • 20. Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study.
    Ciapparelli A, Dell'Osso L, Bandettini di Poggio A, Carmassi C, Cecconi D, Fenzi M, Chiavacci MC, Bottai M, Ramacciotti CE, Cassano GB.
    J Clin Psychiatry; 2003 Apr 15; 64(4):451-8. PubMed ID: 12716249
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.